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An essential feature of the adaptive immune system is the proliferation of antigen-specific lym-
phocytes during an immune reaction to form a large pool of effector cells. This proliferation must
be regulated to ensure an effective response to infection while avoiding immunopathology. Recent
experiments in mice have demonstrated that the expansion of a specific clone of T cells in response
to cognate antigen obeys a striking inverse power law with respect to the initial number of T cells.
Here, we show that such a relationship arises naturally from a model in which T cell expansion is
limited by decaying levels of presented antigen. The same model also accounts for the observed
dependence of T cell expansion on affinity for antigen and on the kinetics of antigen administration.
Extending the model to address expansion of multiple T cell clones competing for antigen, we find
that higher affinity clones can suppress the proliferation of lower affinity clones, thereby promoting
the specificity of the response. Employing the model to derive optimal vaccination protocols, we
find that exponentially increasing antigen doses can achieve a nearly optimized response. We thus
conclude that the dynamics of presented antigen is a key regulator of both the size and specificity
of the adaptive immune response.
I. INTRODUCTION
During an immune reaction, antigen-specific lympho-
cytes proliferate multiple times to form a large pool of ef-
fector cells. T cell expansion must be carefully regulated
to ensure efficient response to infections while avoiding
immunopathology. One challenge to regulation is that
the number of naive T cells specific to any given anti-
gen is biased by the VDJ recombination machinery and
thymic selection [1], and the total number of T cells spe-
cific to an antigen further depends on previous infections
with the same or similar pathogens [2]. As a result, there
are large variations in the number of precursor cells prior
to an immune response. How does the adaptive immune
system properly regulate its lymphocyte expansion given
varying precursor numbers?
In a recent study by Quiel et al. [3], transgenic CD4+
T cells specific for a peptide from cytochrome C were
adoptively transferred into mice. The number of trans-
genic T cells was then tracked in response to immuniza-
tion with cytochrome C (Fig. 1A). It was found that fold
expansion of the transgenic T cells depends as an in-
verse power law on the number of transferred precursor
cells (Fig. 1B). Here, we propose a simple mathematical
model to describe the dynamics of T cell expansion. We
show that the power-law behavior arises naturally when
T cell proliferation is limited by decaying antigen avail-
ability and we predict how the power-law exponent is re-
lated to the rates of lymphocyte proliferation/death and
of antigen decay. Our proposal adds to previous model-
ing efforts to explain the surprising power-law relation in
terms of negative feedback regulation [4] or the grazing
of peptide-major histocompatibility complexes (pMHCs)
by T cells [5]. We extend our analysis of the model to
show that it can also explain how T cell expansion de-
pends on antigen affinity [6] and on the the kinetics of
antigen administration [7]. We thus identify the dynam-
ics of presented antigen as a key regulator of the size of
an immune response.
II. RESULTS
A. A simple model explains power-law dependence
of fold expansion on precursor number
We propose a minimal model of T cell expansion in
which T cell proliferation is regulated by the level of pre-
sented cognate antigen (Fig. 1D). Our model has two
experimentally motivated features: T cells proliferate at
a saturated rate at high pMHC concentrations [3] and
pMHC turnover leads to decaying antigen levels over time
[8, 9]. We describe the dynamics of the number of specific
T cells, T , and cognate pMHCs, C, using the equations
dT
dt
= α
TC
K + T + C
− δT, (1)
dC
dt
= −µC. (2)
Eq. 1 follows from the assumption that T cells are stim-
ulated to divide at a maximum rate α by binding to
pMHCs. However, the actual rate of T cell proliferation
depends on how many cognate antigens are presented
and on a saturation constant K related to the affinity
between the T cell receptor and the pMHC. The form
of the proliferation term in Eq. 1 arises from considering
competition between T cells for binding to pMHCs [10]
(SI Text A 2). Finally, T cells die at a rate δ, and pMHC
complexes decay at a rate µ from their initial number.
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FIG. 1: Limitation of T cell expansion by antigen decay can explain the power-law dependence of fold expansion on the initial
number of cognate T cells. (A) Transfer of transgenic T cell clones into recipient mice allows monitoring T cell proliferation in
vivo in response to cognate antigen stimulation [3, 6]. (B,C) Comparison of experimental data from [3] with model predictions.
(B) Factor of expansion at day 7 as a function of the number of precursor T cells (crosses: geometric mean, error bars: ±
SE). (C) T cell and pMHC number versus time for 300 and 30,000 initial transgenic T cells (crosses: geometric mean, dots:
individual mice). (D) Schematic of the model. Dendritic cells take up antigens, process them into short peptides, and present
these on major histocompatibility complexes (MHCs) on their surfaces. T cells bind to peptide-MHC complexes (pMHC) via
T cell receptors (TCRs). Recognition of cognate pMHC stimulates T cells to proliferate and continual antigen stimulation is
needed to maintain proliferation. Turnover of pMHCs leads to decay of presented peptides over time. Fitted model parameters
and asymptotic standard errors: α = 1.5 ± 0.3/day, µ = 1.2 ± 0.5/day, δ = 0.22 ± 0.21/day, log10 C(0) = 6.7 ± 1.1. We fixed
K = 0.0 (upper bound from fit ' 700).
We fit the model to experimental data from Quiel et al.
[3] on the relationship between the number of precursor
transgenic CD4+ T cells and fold expansion (Fig. 1B) –
here defined as the number of transgenic T cells at day
7 divided by the number of transgenic T cell at day 0
– as well as to time courses of transgenic T cell popula-
tion sizes (Fig. 1C). The model naturally reproduces the
observed power-law dependence of fold expansion, and it
also recapitulates the observed biphasic time course of T
cell expansion: exponential proliferation at early times
followed by a cross-over into a phase of slowly decreasing
T cell numbers. The model furthermore correctly pre-
dicts that the proliferation phase ends earlier for higher
precursor numbers.
Given the simplicity of the model we can readily
understand the power-law behavior. For small times
the amount of pMHCs is saturating for T cell binding,
C(t)  K and C(t)  T (t), so that T cells prolifer-
ate exponentially, T (t) ' T (0)e(α−δ)t. This exponen-
tial proliferation proceeds until the pMHC concentration
C(t) ' C(0)e−µt decays below the saturation level. This
occurs at a transition time t? when one of the two con-
ditions for saturation is no longer fulfilled, i.e. when
C(t?) ≈ T (t?), or when C(t?) ≈ K. The former case
implies a slowdown of expansion due to competition, the
latter a slowdown due to the limited affinity of the T
cell for the antigen (with a crossover between the two as
shown in Fig. S1). Here, from our fitted parameters we
infer the system is in the competition-limited regime (the
effects of affinity are discussed in the next subsection), so
that the characteristic time t? is set by C(t?) ≈ T (t?),
from which we have
t? =
1
α− δ + µ log
C(0)
T (0)
. (3)
After this time, proliferation of T cells rapidly slows
down as pMHC levels continue to decline. Neglecting
the small additional T cell proliferation and decay be-
yond this time, the fold expansion is given by
T (t?)
T (0)
≈
(
C(0)
T (0)
)(α−δ)/(α−δ+µ)
. (4)
Using the parameter estimates in Fig. 4 caption the max-
imum value of t? is smaller than 7 days, so Eq. 4 provides
a good estimate of the fold expansion (Fig. S2). Thus the
model naturally yields an inverse power-law dependence
of T cell amplification T (t?)/T (0) on the initial T cell
population T (0). Additionally, Eq. 3 can account neatly
for the earlier timing of the peak population size at higher
precursor numbers.
Importantly, Eq. 4 makes concrete predictions regard-
ing how the fold expansion depends on system param-
eters. For example, it predicts the dependence of the
3power-law exponent of fold expansion on the rates of
T cell proliferation/decay and antigen decay. It also
predicts a uniform increase in fold expansion if C(0) is
increased. This has been observed experimentally [3,
Fig. 5A]: either an increase in the antigen dose or in the
number of antigen-presenting cells leads to a uniform in-
crease of fold expansion across precursor numbers. Our
model further predicts that a transfer of transgenic T
cells after a time delay tdelay relative to antigen admin-
istration leads to a smaller fold expansion by a factor of
e−tdelayµ(α−δ)/(α−δ+µ), compared to Eq. 4 with T (tdelay)
in place of T (0), as some of the presented antigens will
already have decayed during the time delay (Fig. S3).
The parameters of the model can be readily inferred
from the data. The rate of decay of T cell numbers af-
ter their peak sets δ. The initial rate of increase of T
cell number is given by α− δ, which sets α. The experi-
mentally observed power-law exponent of ≈ −0.5 implies
α− δ ≈ µ, from which we can infer µ. Finally, we obtain
an upper limit on the saturation constant K from the ob-
servation that the power-law holds down to the smallest
experimental precursor numbers (Fig. 1B); with a higher
K the power law breaks down for the lowest precursor
numbers (Fig. S4). More precisely, the condition K 
C(t?) implies K  C(0)(α−δ)/(α−δ+µ)T (0)µ/(α−δ+µ).
Our model formulation has been deliberately simple
to highlight our proposed explanation for the power-law
relation observed in [3]: namely competition among an
exponentially increasing number of T cells for an expo-
nentially decreasing number of pMHC complexes. The
model can be extended in a number of ways without al-
tering the basic behavior. First, one might ask how the
results change for a more complicated dynamics of the
pMHC number that includes the initial uptake and pro-
cessing of antigen by the antigen presenting cells as was
done in [5]. A simple analysis shows that the power-law
scaling continues to hold as long as there is no new pro-
cessing of antigen into pMHC for times larger than the
smallest t? (SI Text B). Second, one might consider ac-
tive depletion of antigens through their interactions with
T cells, also known as T cell grazing [5]. We can modify
the dynamical equations to include the effect of grazing
while keeping the other aspects of the model intact (SI
Text C). Simulations and mathematical analysis of this
modified model show that it exhibits similar dynamics
and can also fit the experimental data. Both models have
in common the same robust mechanism for generating a
power law: T cells proliferate at a constant rate until the
exponential decay of cognate pMHCs causes proliferation
to cease.
B. Dependence of T cell expansion on antigen
affinity
T cells only respond to ligands that bind sufficiently
strongly to their T cell receptor, which is the basis of
the specificity of the adaptive immune system. Above
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FIG. 2: Limitation of T cell expansion by antigen decay can
account for the power-law dependence of fold expansion on
affinity. (A,B) Comparison of data from an experiment with
Listeria monocytogenes strains expressing different antigens
[6] with model predictions. (A) Factor of expansion of the
transgenic T cells at day 7 relative to day 4 versus the con-
centration of different pMHCs needed to elicit half-maximal
Interferon-γ response from the T cells. (B) T cell number
versus time for the different strains. Fitted model parameters
and asymptotic standard error: α = 2.47 ± 0.13/day, µ =
3.1 ± 0.3/day, δ = 0.23 ± 0.06/day, log10 C(4) = 3.22 ± 0.17,
T (4) = 0.92 ± 0.10. The number of transgenic T cells are
calculated from their fraction f of total T cells as f/(1 − f)
with the number at day 4 set to 1.
this binding threshold there is a large range of possible
affinities that can stimulate T cell expansion. How does
the affinity of a T cell clone for the pMHC, as typically
measured by a dissociation constant, affect its expan-
sion? In our model, affinity is captured by the parameter
K, which is equal to the concentration of free pMHC at
which the proliferation rate of the T cells is half-maximal
in the non-competitive regime. Clearly, affinity is impor-
tant whenever pMHC concentrations are near or below
K. Applying our model to affinity-limited expansion in
the context of a pMHC concentration that is decreasing
over time makes specific predictions about how T cell
proliferation depends on affinity, which we compare to ex-
perimental data from [6]. Additionally, we demonstrate
that affinity can play an important role in expansion for
mixtures of T cells of different affinities even if pMHC
concentrations are higher than all Ks.
When proliferation of T cells is limited by their antigen
affinity, low affinity T cells stop proliferating earlier, and
consequently their fold expansion is smaller. In contrast
to the competitive regime (Eq. 3), the characteristic time
t? at which exponential proliferation stops is now set by
C(t?) ≈ K. This yields a logarithmic dependence of t?
on the binding constant,
t? =
1
µ
log(C(0)/K), (5)
and we find that the fold expansion scales as
T (t?)
T (0)
≈ (C(0)/K)(α−δ)/µ , (6)
i.e. as an inverse power law with respect to K.
4We compare our model predictions to data from an-
other adoptive transfer experiment, where the effect of
antigen affinity was examined [6]. In this study the ex-
pansion of transgenic CD8+ T cells was tracked in re-
sponse to an infection by Listeria monocytogenes. Dif-
ferent strains of the bacterium were engineered to express
altered ligands with different affinities for the transgenic
T cells. This experimental design allowed direct study
of how T cell expansion depends on antigen affinity in
vivo. A reanalysis of the published data confirms our
predictions that the fold expansion depends as a power
law on antigen affinity (Fig. 2A, data points) and that
peak population sizes are reached earlier when affinity is
lower (Fig. 2B, data points).
Going beyond these qualitative predictions we can fit
our model to the data of [6] quantitatively. To do so we
set K to the experimentally determined concentration of
pMHC needed for half of T cells to show a detectable
interferon-γ response. We then fit the rates α, µ, δ as
well as the day 4 pMHC concentration C(4) and T cell
number T (4) to the time course data. In the affinity-
limited regime the denominator in Eq. 1 can be approx-
imated by K + C, which makes the equation linear in T
and thus independent of the relative T cell and pMHC
numbers. The fitted model closely reproduces both the
observed dependence of the fold expansion on the affinity
(Fig. 2A) and the full time courses of T cell numbers for
different affinities (Fig. 2B).
So far, we have considered proliferation of a clone of T
cells with a particular affinity for the pMHCs. However,
the preinfection T cell repertoire specific to an antigen
is typically broad with many different T cell clones of
different affinities participating. How does the presence
of other T cells of different affinities affect proliferation
of a particular T cell clone? Following [10] we generalize
our competitive binding model to multiple T cell popu-
lations of varying affinities (SI Text A). When pMHCs
are abundant the presence of other T cells with differ-
ent affinities does not change proliferation of individual
clones (Eq. A20). However, when T cells are competing
for antigens high affinity T cells enjoy preferential bind-
ing to antigen, with the magnitude of the preference set
by the affinity ratio (Eq. A21). This implies, perhaps sur-
prisingly, that even for pMHC concentrations well above
all T cell affinities, the higher affinity T cells proliferate
much faster (Fig. 3).
How differential proliferation of T cells of different
affinities affects overall fold expansion depends on both
the onset and extent of the competitive regime. For ex-
ample, consider the dynamics of two T cell clones with
relatively high and low affinities for the same pMHC anti-
gen (Fig. 3). If the pMHC concentration declines from
a very high saturating initial level, most of the expan-
sion happens before the onset of competition, and so the
overall difference in fold expansion is low (Fig. 3A). How-
ever, high affinity T cells can still effectively shut off pro-
liferation of a smaller population of low affinity T cells
before these would stop proliferating on their own, re-
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FIG. 3: High affinity T cells can outcompete low affinity T
cells for access to pMHCs, even when pMHC concentrations
exceed all T cell affinities. (A-D) Comparisons of the time
courses of expansion of mixtures of two types of T cells with
high, K1 = 1, and low, K2 = 10, affinities (solid curves), to
the expansion of the T cells on their own (dashed curves).
(A,B) Proliferation driven by a large, but exponentially de-
creasing number of pMHCs (µ = 1.1) starting from equal
(A) and unequal (B) initial T cell numbers. (C,D) Prolifer-
ation driven by a small, but exponentially increasing num-
ber of pMHCs mimicking antigen dynamics early in an in-
fection (C(t) ∝ eγt). Competition outcome depends strongly
on whether pMHC levels increase faster γ = 3 (C) or slower
γ = 0.5 (D) than T cells proliferate. Parameters: α = 1.2,
δ = 0.
sulting in a lowered fold expansion of the low affinity T
cells (Fig. 3B). In the experiments of Zehn et al. [6] the
transgenic T cell clones expanded to comparable num-
bers at day 4 when stimulated by antigens with different
affinities (Fig. 2B), which suggests that affinity did not
play a major role in the first 4 days of expansion. In our
model, initial T cell expansion is independent of affinity
as long as the pMHC concentration rises quickly to levels
which saturate proliferation for all T cells (Fig. 3C). By
contrast, if pMHC concentration rises more slowly than
the maximum rate of T cell proliferation, high affinity
T cells can outcompete low affinity T cells for pMHCs
and thereby suppress expansion of the low affinity T cells
(Fig. 3D).
In summary, the same model used to explain the
power-law dependence of expansion on initial cell num-
bers for CD4+ T cells is also able to quantitatively ex-
plain the effect of affinity on CD8+ T cell expansion.
The two experiments reveal limiting cases of the model,
competition-limited versus affinity-limited. In between
these limiting cases, the effects of antigen affinities, T
5FIG. 4: Impact of antigen kinetics on T cell proliferation. (A)
Antigen input schedules: single pulse, constant input, and ex-
ponentially increasing input (increase each day by 5 fold as in
[7]). (B) Dynamics of pMHCs. (C) Dynamics of T cells. (D)
The optimal schedule is close to the experimentally used expo-
nential schedule. The antigen input schedule over 4 days that
optimizes fold expansion at day 6 was computed numerically
using a projected gradient algorithm [11]. (E) Fold expansion
for exponential schedules as a function of the fold increase per
day, with the experimental schedule indicated by the dot. Pa-
rameters: α, µ, δ as in Fig. 2, K = 10, C(0) = 0, T (0) = 100,
total administered antigen 2 · 106.
cell numbers, and pMHC concentrations combine in in-
teresting ways to differentially influence T cell expansion.
C. Dependence of T cell expansion on antigen
kinetics
A recent experimental study with mice [7] has shown
that spreading vaccine antigen administration into mul-
tiple, smaller doses instead of a single, larger dose can
increase CD8+ T cell responses. Is our model consistent
with this observed dependence of T cell expansion on
antigen dosing?
To address this question we add a time-varying anti-
gen input rate ν(t) to Eq. 2 (see Materials and Methods
Eq. 8). We simulate the system of equations for three
cases with equal total antigen input but different sched-
ules (Fig. 4A): (1) a single antigen pulse of 1-day length,
(2) constant input over 4 days, and (3) exponentially in-
creasing input over 4 days. These inputs lead to markedly
different pMHC levels over time (Fig. 4B). To mimic the
experimental protocol of [7], we analyze the impact of
these different pMHC kinetics on T cell numbers at day
6 (Fig. 4C). We find that the exponentially increasing in-
put leads to the largest T cell expansion (orange curve),
ahead by a factor of 2 relative to constant antigen dosing
(green curve), and the single shot protocol (blue curve).
While the experiment shows a larger fold-advantage of
the exponential protocol over the constant protocol, our
model correctly predicts the observed order of response
amplitudes. Our model provides a simple explanation for
the different potencies of the protocols. Early on when T
cell numbers are very low, even low pMHC concentrations
are sufficient for all T cells to proliferate at their maximal
rate. Later on, as T cell numbers increase, competition
of T cells for pMHC can limit their expansion. Ideally,
pMHC levels should rise in tandem with T cells to mini-
mize competition and maximize stimulation at all times.
By contrast, dosing schedules with high levels of pMHCs
at early times are wasteful of the finite antigen budget:
While initial pMHC levels are higher than needed for full
T cell stimulation, these levels decay to become insuffi-
cient to stimulate the rising T cell population at later
times. The exponentially increasing input protocol bet-
ter synchronizes antigen levels with T cell proliferation
and therefore leads to a higher fold expansion. Indeed, we
find that an optimized daily-dose protocol is close to the
experimentally used exponential protocol (Fig. 4D) us-
ing the derived parameters for CD8+ T cells from Fig. 2.
It is worth noting that experimental choice of 5-fold in-
creases of dose per day [7] is surprisingly close to optimal
among exponential protocols (Fig. 4E).
III. DISCUSSION
Prompted by the surprising observation of a power-
law dependence of T cell fold expansion on initial cell
numbers [3], we developed a simple mathematical model
in which T cell proliferation is stimulated by a dynami-
cally changing number of cognate pMHC molecules, and
showed that it quantitatively yields the observed power
law. We then explored more generally how T cell num-
bers, TCR affinity for antigen, and the dynamics of
pMHC presentation combine to regulate T cell expansion
in different regimes. Testing these results against other
experimental data, we found that the model correctly
predicts a power-law dependence of T cell expansion on
affinity for lower affinity antigens [6], and also predicts
the observed enhanced efficacy of stretching a fixed total
antigen dose over several days [7]. We further explored
competition among multiple T cell clones with differing
affinities, and generated testable predictions for future
experiments.
The core of our model is that T cell expansion is reg-
ulated by dynamically changing levels of presented anti-
gens. The dynamics of pMHCs is assumed to be char-
acterized by a fast processing of antigens by antigen-
presenting cells followed by a slower decay. The first
assumption of rapid processing seems well justified for
the subcutaneous injection of antigens employed in [3],
but might be more questionable in [6], where live repli-
cating bacteria are used, as this might lead to continued
6processing of new antigens by dendritic cells. However, as
the bacterial load declines rapidly after reaching a peak
at three days post-infection [12, 13], newly generated
pMHCs likely play a small role compared to the turnover
of the already presented pMHCs at the late stages of in-
fection analyzed in Fig. 2. The second assumption of the
decay of presented pMHCs has a known mechanistic ba-
sis in the turnover of MHCs by ubiquitylation [14] and
in the apoptosis of activated antigen presenting cells [15].
Furthermore, our inferred decay constants are within the
range of decay constants reported for different antigens
bound to dendritic cells [8] and are also roughly com-
patible with direct measurements of the decrease of the
stimulatory capacity of antigen-presenting cells in trans-
genic mice after switching off inducible antigen produc-
tion [9]. One limitation of our model, particularly for
replicating antigens, is that we have neglected any influ-
ence of the epitope specific pMHC density on the surface
of an antigen presenting cell, which may also play a role
in determining T cell stimulation and expansion [16].
The kinetics of antigen administration has been shown
to influence the magnitude of T cell [7] and B cell [17]
immune responses. This finding has implications for the
rational design of vaccination strategies [18], but open
questions remain regarding how to optimize dosing for
high magnitude of response and/or high affinity of the
responding cells [17]. Our modeling suggests that expo-
nentially increasing doses are close to optimal for maxi-
mizing the magnitude of T cell response. We further find
that selection for higher affinity is strongest when T cells
compete for antigen stimulation. Selection for affinity is
thus predicted to be more stringent for lower or more
slowly increasing antigen levels and for larger or faster
growing prior T cell populations. This could have im-
portant implications for patterns of immunodominance
in primary versus secondary infections: In secondary in-
fections competition is expected to be stronger as preex-
isting memory cells specific to the pathogen are usually
present in higher numbers and can also proliferate faster.
Looking ahead, our model could be further extended
to make it more realistic. Including single-cell stochastic-
ity could help clarify how reproducible population-level
expansion arises despite stochasticity at the single-cell
level [19] and would also allow connections to recent ex-
perimental studies, that have revealed substantial hetero-
geneity of the immune responses of single-cells [20]. Fur-
thermore, the model could be extended to account for the
diverse compartments (different lymph nodes, the spleen,
different tissues) [2] and T cell subtypes [4] involved in
an immune response. Spatial or cellular heterogeneity
can create separate niches in which T cells compete for
proliferation and survival, which may provide a further
layer of regulation of T cell expansion.
Among the open questions raised in our study we high-
light two: First, other than regulating T cell expansion
during an acute infection, how else might antigen presen-
tation levels influence T cell populations? Do they play a
role in thymic selection or the dynamics of naive T cells
competing for self-antigens? Specifically, recent work in
ecology [21] suggests that T cell grazing, which consumes
antigens, could allow for the coexistence of a diverse naive
repertoire despite competition for self-antigens. Second,
regulation of T cell population dynamics can be achieved
by tuning of system parameters. For example, smart con-
trol of the lifetime of presented pMHC complexes could
induce the “right” amount of T cell amplification. Might
system parameters have evolved to be close to optimal
and/or could some parameters also be regulated during
an immune response to provide a robust response to in-
fections while avoiding autoimmunity?
IV. MATERIALS AND METHODS
a. Experimental studies. We used previously pub-
lished data from [3] and [6]. In both studies transgenic
T cells were transferred into recipient mice and their ex-
pansion in response to antigenic stimulation was subse-
quently studied. Quiel et al. [3] studied the response of
5C.C7 CD4+ T-cells to a subcutaneous administration of
pigeon cytochrome C and lipopolysaccharide. The num-
ber of transgenic T cells was determined by quantitative
real-time PCR calibrated against a reference with known
T cell numbers. Zehn et al. [6] used OT-1 CD8+ T cells
specific to an ovalbumin peptide. They injected into the
mice Listeria monocytogenes expressing either wild type
ovalbumin or altered ovalbumin with specific amino acid
substitutions in the antigenic region. The percentage of
transgenic T cells within the spleen of mice was quan-
tified by flow cytometry to measure the relative expan-
sion of transferred versus endogeneous cells. To assess
T cell affinity for the different ligands they were stim-
ulated with RMA-S cells loaded with different doses of
antigen for five hours. T cell responses were assessed by
Interferon-γ staining and quantified by the peptide dose
needed for half-maximal response probability.
b. Model equations. We consider deterministic
birth-death type models for the dynamics of the T cell
population, T , and the concentration of pMHCs, C, of
the following form
dT
dt
= α(T,C,K)T − δT, (7)
dC
dt
= ν(t)− µ(T,C,K)C. (8)
By binding to pMHCs, T cells are stimulated to pro-
liferate at a rate α(T,C,K), which can depend on the
availability of antigen, competition with other T cells,
and on a parameter K related to the affinity of the T cell
receptor for pMHC (SI Text A). T cells die at a rate δ.
The uptake of antigen and its processing leads to a time-
varying influx ν(t) of pMHCs. The pMHC complexes
decay at a rate µ(T,C,K), which may depend on T cell
numbers (see SI Text C). In the main text we make a
number of simplifying assumptions regarding α and µ.
Several more general cases are considered in the SI Text.
7c. Numerical simulations. The differential equa-
tions describing the T cell / pMHC dynamics were inte-
grated using a Runge-Kutta method of order 4(5) due to
Dormand and Prince (routine dopri5 in scipy [22]). Pa-
rameters were determined using least-square fits to log-
transformed mean cell numbers weighted by the number
of repeat experiments. Asymptotic standard errors of the
parameters were calculated based on the residual covari-
ance matrix. An upper bound for K was defined by the
value of K which leads to a unit increase of the sum of
squared residuals [23].
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Significance
Antigen-specific T cells proliferate multiple times dur-
ing an immune reaction to fight against disease. This ex-
pansion of T cells must be carefully regulated to ensure
an effective defense while avoiding autoimmunity. One
challenge to regulation is that the initial size of antigen-
specific T cell clones can be quite variable. Intriguingly,
a recent study in mice found that the fold expansion of
a T cell clone depends as an inverse power law on its
initial size. We propose a simple mathematical model
which naturally yields the observed power-law relation.
Our model accounts for multiple experiments on T cell
proliferation, suggests optimal vaccination protocols, and
highlights the dynamics of presented antigen as a key reg-
ulator of the size of an immune response.
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8SI Text A: Competitive binding model
The preinfection T cell repertoire specific to an anti-
gen is typically broad consisting of many T cell clones
of varying affinities. Competition between all of these
T cells for binding to a limited number of pMHC com-
plexes can reduce T cell proliferation. To make our work
self-contained we derive a mathematical framework to an-
alyze how such competition influences T cell expansion,
largely following earlier work by Perelson and DeBoer
[10] and Borghans et al. [24].
1. General framework
We consider the following dynamical equations to de-
scribe the expansion of multiple T cell clones competing
for the cognate antigen:
dTi
dt
= αBi − δTi, (A1)
dC
dt
= −µC. (A2)
The first equation describes the dynamics of the number
of T cells, Ti, in the ith clone, with i running from 1 to the
number of clones n that have significant affinity for the
antigen. All T cells are assumed to proliferate at a rate α
upon binding to pMHC complexes; thus the overall rate
of proliferation of T cells in the ith clone is proportional to
the number of bound T cell-pMHC complexes Bi. All T
cells are assumed to die at a rate δ. The second equation
describes the dynamics of the number of cognate pMHCs,
C. The pMHCs are presented on the surface of antigen-
presenting cells and are assumed to decay at a rate µ.
The specific form of the proliferation term in Eq. A1
can be derived by considering the following scheme [10]
which resembles an enzymatic reaction:
Tui + Cu
kai

kdi
Bi
kpi→ 2Tui + Cu, (A3)
where Tui is the number of unbound T cells in the ith
clone, Cu is the number of unbound pMHCs, and kai, kdi
and kpi are, respectively, rate constants for association
and dissociation of the bound complex Bi and for the
proliferation of T cells in ith clone upon binding. After
the T cell is stimulated to divide it dissociates from the
APC leaving the pMHC unbound.
The dynamical equations corresponding to the above
scheme are:
dTui
dt
= (2kpi + kdi)Bi − kaiTuiCu, (A4)
dBi
dt
= kaiTuiCu − (kpi + kdi)Bi. (A5)
The total number of T cells in the ith clone is the sum
of the number of unbound T cells and bound complexes
Ti = Tui + Bi, so that adding the above two equations
together we have
dTi
dt
= kpiBi, (A6)
which gives rise to the proliferation term in Eq. A1 after
setting kpi to α.
Assuming that the binding/unbinding kinetics is much
faster than the proliferation of T cells, we adopt the
quasi-steady-state approximation dBi/dt = 0 for all the
bound complexes. This leads to the following equation
TuiCu −KiBi = 0, (A7)
where Ki = (kpi + kdi)/kai is the saturation constant re-
lated to the affinity between the T cell receptors in the ith
clone and the pMHC. Expressing the number of unbound
T cells and pMHCs in terms of the total numbers of T
cells and pMHCs and of bound complexes, Tui = Ti−Bi
and Cu = C −
∑
Bi, we finally obtain an equation relat-
ing the number of bound complexes to the total numbers
of T cells Ti and of pMHCs C and the saturation con-
stants Ki:
(Ti −Bi)(C −
n∑
j=1
Bj)−KiBi = 0. (A8)
The above set of equations (with i running from 1 to
n) can be readily solved numerically to find {Bi} given
{Ti}, C and {Ki}. Analytical solutions are also possible
in special cases, e.g. when competition only involves one
or two T cell clones or for certain limiting cases.
2. Competitive binding for a single T cell clone
Following the general framework, we first consider the
simplest case of competitive binding within a single pop-
ulation of T cells, all with equal affinity for the cognate
antigen. This case can be relevant in practice. For exam-
ple, in experiments a single clone of transgenic T cells and
cognate antigens with high specificity for each other may
be transferred together [3], or in a natural setting one of
the T cell clones in a preinfection repertoire may have a
much higher specificity for a particular pathogen-derived
antigen than the other clones, so that competition occurs
mainly within this highly specific population of T cells.
From Eqs. A1 and A2, the dynamical equations for the
expansion of a single T cell clone are
dT
dt
= αB(T,C,K)− δT, (A9)
dC
dt
= −µC, (A10)
where the analytical expression B(T,C,K) can be de-
rived from the single-clone version of Eq. A8:
B2 − (K + T + C)B + TC = 0. (A11)
9This quadratic equation has the solution
B =
1
2
[
K + T + C −
√
(K + T + C)2 − 4TC
]
, (A12)
where the choice of the minus sign is determined by the
conditions that the number of bound complexes is smaller
than the total numbers of T cells and pMHCs, B < T
and B < C. When TC  (K + T +C)2, we can expand
the exact solution Eq. A12 with respect to the small pa-
rameter TC/(K + T + C)2. This leads to a convenient
approximate solution for B:
B =
TC
K + T + C
. (A13)
Eq. A13 has been obtained previously in [10]. (The
largest deviation between the exact and approximate ex-
pressions occurs when K → 0 and T = C, where there is
a factor of 2 difference between the exact solution B = T
and the approximate solution B = T/2.) Substituting
the approximate solution Eq. A13 into Eq. A9, we ob-
tain Eqs. 1 and 2 in the main text for the dynamics of
the T cell and pMHC numbers.
3. Competitive binding for two T cell clones
T cell dynamics becomes more nuanced when two T
cell clones with different affinities compete for binding
to the same antigen. When the antigens are abundant,
all T cells can proliferate freely. However, as the level
of antigen decays, competition can differentially reduce
the proliferation of T cells in the different clones. The
expansions of two competing T cell clones are described
by Eqs. A1 and A2 with the total number of clones n = 2.
The specific forms of the numbers of the bound complexes
B1 and B2 in the dynamical equations can be derived
from Eq. A8:
(T1 −B1)(C −B1 −B2)−K1B1 = 0, (A14)
(T2 −B2)(C −B1 −B2)−K2B2 = 0. (A15)
Since the above two equations are symmetric with re-
spect to interchange of the subscript indices 1 and 2,
the analytical expressions for B1 and B2 must preserve
the symmetry, i.e., B1 = f(T1, T2, C,K1,K2) and B2 =
f(T2, T1, C,K2,K1). Therefore, we first obtain the solu-
tion for B1, and the solution for B2 can then be found by
interchanging the subscripts 1 and 2 in B1. Combining
Eqs. A14 and A15, we obtain a cubic equation for B1:
aB31 + bB
2
1 + cB1 + d = 0, (A16)
where
a = K1 −K2,
b = K1T2 +K2T1 − (K1 −K2)(K1 + C + T1),
c = −T1 [K1T2 +K2T1 +K1K2 + C(2K2 −K1)] ,
d = K2CT
2
1 . (A17)
We find the solution for B1 following standard methods
for solving cubic equations,
B1 = − 1
3a
[
b+ Re
(
(−1 +
√
3i)Ω
)]
, (A18)
where Re means real part, and
Ω =
3
√
Q± i
√
4P 3 −Q2
2
(A19)
with P = b2 − 3ac and Q = 2b3 − 9abc+ 27a2d. We use
the plus sign in Ω when K2 > K1 and the minus sign
when K1 < K2.
These analytical expressions were employed to gener-
ate the results shown in Fig. 3 in the main text.
4. Competitive binding in limiting cases
Beyond the simplest cases of competitive binding for
one or two T cell clones, analytical solutions for Eq. A8
are also possible in certain limiting cases.
In the non-competitive limit, when the number of
pMHCs bound to T cells is much smaller than the to-
tal number of pMHCs,
∑
Bi  C, we can neglect
∑
Bj
in the term C −∑Bj in Eq. A8 and obtain
Bi ≈ TiC
Ki + C
. (A20)
Expressing the condition
∑
Bi  C in terms of the
known parameters C, Ti and Ki, the assumption under-
lying Eq. A20 can be rewritten as
∑
Ti/(Ki + C)  1.
The expression A20 corresponds to independent prolif-
eration of T cells in all clones, as expected in the non-
competitive limit. A less crude approximation obtained
by only dropping the BiBj terms in Eq. A8 is provided
in [10].
In the highly competitive limit, when the number of
bound T cells is much smaller than the total number of
T cells in each clone, Bi  Ti, we can neglect Bi in the
term Ti −Bi in Eq. A8 and obtain
Bi ≈ C
1 + n∑
j=1
Tj
Kj
−1 Ti
Ki
. (A21)
Expressing the condition Bi  Ti in terms of the known
parameters, the assumption underlying Eq. A21 can
be rewritten as C/Ki  1 +
∑
(Tj/Kj). Note that
C(1+
∑
(Tj/Kj))
−1 in Eq. A21 is a constant prefactor for
all the bound species. Therefore, the fraction of bound T
cells in each clone is inversely proportional to their satu-
ration constant. Interestingly, as long as T cell numbers
are sufficiently large that Bi  Ti, Eq. A21 holds even
when C  Ki, where naively one might have expected
the competition to be affinity independent.
10
SI Text B: Influence of initial antigen dynamics
The dynamics of antigen presentation can be more
complex than simple exponential decay from an initial
level. Complications include the uptake and processing
of antigens by the antigen presenting cells or continued
generation of new antigens, e.g. due to pathogen repli-
cation during a natural infection. How might these com-
plications in antigen dynamics influence the power-law
dependence of fold expansion on the initial T cell num-
ber?
Here, we show that the power-law scaling continues
to hold for a larger class of antigen dynamics. Specif-
ically, we define a time t′ after which there is no new
processing of antigens into pMHCs. The initial antigen
dynamics before t′ can be arbitrary as long as the num-
ber of antigens remains above the saturating level for T
cell proliferation. This ensures independent proliferation
of T cells during the initial stages, and hence a constant
ratio between T (t′) and T (0) for all precursor numbers.
Antigen dynamics beyond t′ will obey exponential decay
C(t) = C(t′)e−µ(t−t
′) as there is no new generation of
pMHCs. Since the number of antigens remains saturat-
ing until t′, the transition from T cell proliferation to
decay happens at a time t? later than t′ for all precursor
numbers. Therefore, in the competition-limited regime
the power-law relation in Eq. 4 in the main text holds
with C(t′) and T (t′) in place of C(0) and T (0),
T (t?)
T (t′)
≈
(
C(t′)
T (t′)
)(α−δ)/(α−δ+µ)
. (B1)
As T (t′) and T (0) only differ by a constant factor, the
full fold expansion preserves the inverse power-law de-
pendence on the initial T cell number: T (t?)/T (0) ∝
T (0)−(α−δ)/(α−δ+µ).
A similar analysis also applies to the affinity-limited
regime.
SI Text C: Grazing model
In the competitive binding model, the power-law scal-
ing between the fold expansion and the initial T cell num-
ber is ensured by the termination of expansion at a fixed
relative level of T cells and pMHC complexes. A simi-
lar outcome can also be achieved in a model in which T
cells actively degrade pMHCs upon binding, based on the
observation that T cells that bind to pMHCs have some
probabilities of acquiring the pMHCs [25, 26]. This pro-
cess of active acquisition has been termed T cell grazing
[5].
In the grazing model, the dynamics of T cells and
pMHCs are described by the following equations:
dT
dt
= α
TC
K + T + C
− δT, (C1)
dC
dt
= −µC − β TC
K + T + C
. (C2)
The last term in Eq. C2 describes the loss of pMHCs
through grazing, where the prefactor β is the rate of
grazing upon binding. For simplicity, we assume in the
following that grazing limits proliferation before compet-
itive binding sets in, i.e. we assume T  K + C so that
the number of bound complexes can be approximated by
TC/(K +C). The model differs from the previous graz-
ing model in [5] in two major ways: In Eqs. C1 and C2,
the T cell proliferation rate saturates at high pMHC con-
centrations, and the rate of grazing has a simple linear
dependence on the T cell number. The grazing term in
Eq. C2 leads to an increased loss of pMHCs at high T
cell numbers. This T cell-induced loss of pMHCs is also
compatible with mechanisms other than grazing. In par-
ticular, the “grazing” term might also be interpreted as a
reduction of pMHCs through T cell-induced pMHC en-
docytosis followed by lysosomal degradation, which has
recently been reported [27].
The grazing model also yields an inverse power-law
dependence of the fold expansion on the initial T cell
number. Here, we provide a simple explanation fol-
lowing our analysis of the competitive binding model.
At small times, the pMHC concentration is saturating
for T cell binding, C(t)  K, so that T cells prolifer-
ate exponentially T (t) = T (0)e(α−δ)t. The initial loss
of pMHCs is mainly due to natural decay, as the rate
of grazing of pMHCs is proportional to T cell number,
which is initially small. Mathematically this means that
C(t) = C(0)e−µt as βT (t)  µC(t). The condition
βT (t) µC(t) holds until a characteristic time
t? =
1
α− δ + µ log
µC(0)
βT (0)
. (C3)
After this time grazing leads to a rapid decline in the
pMHC level. Therefore T cell proliferation ceases and
the total number of T cells after expansion can be ap-
proximated by T (t?) = T (0)e(α−δ)t
?
. The fold expansion
is thus approximately
T (t?)
T (0)
≈
(
µC(0)
βT (0)
)(α−δ)/(α−δ+µ)
, (C4)
displaying an inverse power-law dependence on the ini-
tial T cell number. Given the similarity of the grazing
model to the competitive binding model, it is not surpris-
ing that the grazing model can also fit the data presented
in Fig. 1B,C (not shown). In both models, the exponen-
tial increase of T cell number, the exponential decay of
pMHCs, and the termination of expansion at a fixed rela-
tive level of T cells and pMHC complexes are the essential
ingredients leading to power laws in the fold expansion
of T cells.
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Supplementary figures
FIG. S1: Dependence of fold expansion at day 7 on precursor number T (0) and saturation parameter K. Parameters as in
Fig. 3.
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FIG. S2: Modeled time courses of T cell and pMHC populations. The estimated peak time t? and peak value T (t?) of the T
cell population as estimated by Eqs. 3 and 4, respectively, are indicated by the blue dot. Parameters as in Fig. 1.
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FIG. S3: Transfer of transgenic T cells after a time delay relative to antigen administration is predicted to decrease fold
expansion. Modeled factor of expansion at day 7 after antigen administration as a function of the time delay for initial T cell
numbers 10 (blue) and 100 (orange). Parameters as in Fig. 1.
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FIG. S4: Modeled T cell dynamics as in Fig. 1 with a saturation parameter K = 104 above the upper bound inferred from the
data. At low precursor numbers, T cell expansion becomes affinity-limited, which caps fold expansion and leads to deviations
from power-law behavior.
